The risk of infections with epcoritamab plus R2 appeared to level off after the first 4 cycles of therapy in the EPCORE FL-1 trial.
Bradley D. Hunter, MD
Advertisement
Articles by Bradley D. Hunter, MD
Advertisement
Latest Updated Articles
EPCORE FL-1 Shows Efficacy and Safety of Epcoritamab Combination TherapySeptember 11th 2026
Advertisement
Advertisement
Trending on CancerNetwork
1
Sac-TMT Improves Survival vs Chemotherapy in Pretreated Endometrial Cancer
2
Pembrolizumab Improves PFS Over Chemo in dMMR Endometrial Cancer
3
Cemiplimab Shows Real-World Efficacy in Advanced NSCLC Study
4
Calderasib Regimen Shows Meaningful Responses in Frontline KRAS G12C+ NSCLC
5